John Aballi - Oct 17, 2023 Form 4 Insider Report for EXAGEN INC. (XGN)

Role
President and CEO, Director
Signature
/s/ Kamal Adawi, as attorney-in-fact
Stock symbol
XGN
Transactions as of
Oct 17, 2023
Transactions value $
-$59,018
Form type
4
Date filed
10/18/2023, 04:05 PM
Previous filing
Sep 6, 2023
Next filing
Feb 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XGN Common Stock Sale -$59K -33.8K -7.52% $1.75 416K Oct 17, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on October 16, 2022.